All 50 states opt into Trump's 'favored nations' drug pricing for Medicaid

Key Points:

• President Trump announced that all 50 states, Puerto Rico, and DC have joined his "most favored nations" drug-price initiative, which aims to lower prescription costs for Medicaid recipients by matching drug prices paid in eight other high-income countries.
• The initiative compelled 26 major pharmaceutical companies to reduce prices for federal agencies, potentially saving states billions annually and allowing reinvestment in healthcare services for roughly 70 million Americans on Medicaid.
• The White House projects the program will save Medicaid $64 billion over 10 years and the broader initiative could save the government $529 billion in the same period.
• Discounts on certain drugs will also be available for uninsured Americans through the new "TrumpRx" platform, addressing affordability beyond Medicaid recipients.
• Health officials, including Medicare and Medicaid administrator Dr. Mehmet Oz and HHS Secretary Robert F. Kennedy Jr., praised the initiative for its potential to improve care for low-income populations and support state budgets.